Beranda › Degenerasi Makula
Uji klinis Degenerasi Makula yang merekrut di AS
55 studi untuk Degenerasi Makula merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Dallas, TX13 studi
- Erie, PA10 studi
- The Woodlands, TX9 studi
- Sacramento, CA8 studi
- Hagerstown, MD8 studi
- Reno, NV8 studi
- Phoenix, AZ7 studi
- Cleveland, OH7 studi
- Houston, TX7 studi
- Salt Lake City, UT7 studi
- Boston, MA7 studi
- Austin, TX7 studi
- Carmel, IN7 studi
- Fort Worth, TX7 studi
- Santa Monica, CA7 studi
- Washington, DC6 studi
- Cincinnati, OH6 studi
- McAllen, TX6 studi
- Philadelphia, PA6 studi
- Mountain View, CA6 studi
- Portland, OR6 studi
- Columbia, SC6 studi
- Nashville, TN6 studi
- Raleigh, NC6 studi
- Naperville, IL6 studi
- Durham, NC5 studi
- Pensacola, FL5 studi
- Spokane, WA5 studi
- Eugene, OR5 studi
- Tampa, FL5 studi
- Fort Lauderdale, FL5 studi
- Lynchburg, VA5 studi
- Orlando, FL5 studi
- San Francisco, CA5 studi
- Syracuse, NY5 studi
- San Antonio, TX5 studi
- Sarasota, FL4 studi
- Jacksonville, FL4 studi
- Ann Arbor, MI4 studi
- Memphis, TN4 studi
Berdasarkan negara bagian
- Arizona11 studi
- California20 studi
- Colorado7 studi
- Connecticut6 studi
- Florida14 studi
- Georgia6 studi
- Illinois13 studi
- Indiana7 studi
- Maryland11 studi
- Massachusetts14 studi
- Michigan9 studi
- Minnesota5 studi
- Mississippi5 studi
- Missouri5 studi
- Nevada8 studi
- New Jersey7 studi
- New York10 studi
- North Carolina11 studi
- Ohio11 studi
- Oklahoma3 studi
- Oregon9 studi
- Pennsylvania17 studi
- South Carolina8 studi
- Tennessee7 studi
- Texas24 studi
- Utah9 studi
- Virginia7 studi
- Washington8 studi
- Wisconsin6 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
National Eye Institute Biorepository for Retinal Diseases
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT01496625A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Menerima pesertaFase 2/3
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Menerima pesertaFase 2/3
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06635148A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Menerima pesertaFase 1/2
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07029945Cell Collection to Study Eye Diseases
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Day – 120 Years · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT01432847A Study in Adults With Geographic Atrophy
Menerima pesertaFase 2
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Menerima pesertaFase 3
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06541704A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
Menerima pesertaFase 1
Usia 6 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07734064The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06319872A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
Menerima pesertaFase 2
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07811726Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Menerima pesertaFase 2
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06659445Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.
Menerima pesertaStudi observasional
Usia 50 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07798323A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Menerima pesertaFase 1
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT03178149A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Menerima pesertaStudi observasional
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07144137Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06965426A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
Menerima pesertaStudi observasional
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06346600SGLT2 Inhibitors in Geographic Atrophy
Menerima pesertaFase 2
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07174687Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Menerima peserta
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06662162A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
Menerima pesertaStudi observasional
Usia 6 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT074255744D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Menerima pesertaFase 1/2
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT05197270A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Menerima pesertaFase 2
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06659549Phase 1 Study of C.001 in Retinal Degeneration
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07594236AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
Menerima pesertaSukarelawan sehat diterima
Usia 50 hingga 89 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06619405A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Menerima pesertaFase 2/3
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07496567Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Menerima pesertaFase 1
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07230834Dari ClinicalTrials.gov, data diambil 4 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.